The Global Pharma & Drug Delivery Summit 2023 would like to welcome all the pharmaceutical professionals and companies, students, researchers, scientists, practitioners, medical specialists, clinical scientists, technologists, and other healthcare professionals to participate at the prestigious Pharma Summit 2023, April 24-26 in Frankfurt, Germany.
This Pharma Summit 2023 revolves around the theme – “Together with Pharma Masterminds: Opportunities, Technology, and Challenges”.
Dr Klaus Pollinger, Head of Manufacturing Science & Technology, Business Unit Solids at Aenova, will present a keynote address on 26 April 2023, on the topic of
"Enabling innovation - challenges and strategies in solid dosage forms drug development services"
Patients benefit from innovative drugs as they are highly specific to pharmacological targets and thus have higher therapeutic efficacy and less side effects. Regarding dosage forms oral solids are favored, as they offer high advantages in patient therapy adherence, stability and world-wide distribution.
Novel Active Pharmaceutical Ingredients (APIs), however, have two main challenges: unfavorable toxicology, i.e. high-potent APIs (HPAPIs), and poor solubility in aqueous environments. Both compromise formulation as oral solid dosage forms. Additionally, drug product development must be executed with a strong focus on time, cost and risk mitigation.
Consequently, CDMO service providers are often the right choice for drug product development services, as they offer flexible and efficient solutions to overcome the above-named challenges.
Learn more in Aenova's presentation at the Pharma Summit 2023.
Aenova supports your drug projects with its long and deep experience in development services up to commercial manufacturing, investments in expanded capacities, new technologies and end-to-end services.